Latest

Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines.

VRX Silica Performance in the First Half of the Financial Year 2023

VRX Silica Performance in the First Half of the Financial Year 2023

VRX Silica Limited (ASX: VRX or Company) is a mineral exploration company that is developing high-quality silica sand projects. Silica sand is used in various industrial applications, including glassmaking, foundry moulds, and construction. The Company is developing several silica sand projects in Western Australia, with significant tonnes of resources. VRX is committed to sustainable and …

VRX Silica Performance in the First Half of the Financial Year 2023 Read More »

Jindalee Resources Limited Releases Half-Yearly Financial Report For The Period Ended On December 31st, 2022: Important Facts And Figures

Jindalee Resources Limited releases half-yearly financial report for the period ended on December 31st, 2022: Important facts and figures

Jindalee Resources Limited (ASX: JRL), (Jindalee, the Company), a mineral exploration company based in Western Australia, releases its half-yearly financial report for the period ended on December 31st, 2022. The Company is aligned with its goals and working on its potential projects. Also, after the reporting period, Jindalee spun off the Australian lithium, nickel, and …

Jindalee Resources Limited releases half-yearly financial report for the period ended on December 31st, 2022: Important facts and figures Read More »

VRX Silica Limited is all set for the Arrow smith North Silica Sand Project: Signed Power LOI with Resources WA

VRX Silica Limited is all set for the Arrowsmith North Silica Sand Project: Signed Power LOI with ResourcesWA

VRX Silica Limited (ASX: VRX) (VRX or Company) has signed a Letter of Intent (LOI) with ResourcesWA, a company specialising in energy and mining consulting. The LOI aims to explore a potential power supply solution for their Arrowsmith North Silica Sand Project by directly utilising gas from a nearby wellhead. The objective of the LOI …

VRX Silica Limited is all set for the Arrowsmith North Silica Sand Project: Signed Power LOI with ResourcesWA Read More »

Jindalee Resources’ McDermitt Lithium Project Is Now The Largest Lithium Deposit In The United States

Jindalee Resources’ McDermitt Lithium Project is Now the Largest Lithium Deposit in the United States

Jindalee Resources Limited (ASX: JRL) (Jindalee, or the Company) announces a significant update on its 100% owned US-based McDermitt Lithium Project. Figure 1: Location Map of McDermitt Lithium Project In the 2022 drilling program, Jindalee Resources completed 21 holes, 10 diamond and 11 Reverse Circulation (RC) at McDermitt to infill and extend the Mineral Resource …

Jindalee Resources’ McDermitt Lithium Project is Now the Largest Lithium Deposit in the United States Read More »

Ajan Reginald: Biotech Entrepreneur

Ajan Reginald: Biotech Entrepreneur

Roquefort Therapeutics (LSE: ROQ, QTCQB: ROQAF) (Roquefort) is an LSE main-market-listed BioTech company exploring the high-value and high-growth oncology market. We at Colitco secured an exclusive interview with Ajan Reginald, CEO of Roquefort Therapeutics. Q: Ajan Reginald, thank you for agreeing to give Colitco an exclusive. Before we get into Roquefort Therapeutics and your company’s …

Ajan Reginald: Biotech Entrepreneur Read More »